Sign In
Buy MNK
$0.116
+0 (+0%)
At Close: Jul 20, 2022
Are Options Traders Betting on a Big Move in Mallinckrodt (MNK) Stock?
12:48pm, Tuesday, 07'th Apr 2020
Investors need to pay close attention to Mallinckrodt (MNK) stock based on the movements in the options market lately.
Are Options Traders Betting on a Big Move in Mallinckrodt (MNK) Stock?
12:48pm, Tuesday, 07'th Apr 2020
Investors need to pay close attention to Mallinckrodt (MNK) stock based on the movements in the options market lately.
CLARET ASSET MANAGEMENT Corp Has $149,000 Holdings in Mallinckrodt PLC (NYSE:MNK)
09:08am, Tuesday, 07'th Apr 2020
CLARET ASSET MANAGEMENT Corp lessened its stake in Mallinckrodt PLC (NYSE:MNK) by 9.4% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commi
Mallinckrodt Shares Resume Trade, Tick To Pre-Market High Of $2.05, Pullback To $1.90 Level
12:00am, Tuesday, 07'th Apr 2020Mallinckrodt: Back To The Negotiating Table
03:01pm, Monday, 06'th Apr 2020
Negative CMS outcome and lenders backing out of financing have dented the prospect of achieving the planned opioid settlement. $610 million bond repayment is ma
Mallinckrodt subsidiary initiates rolling submission of StrataGraft BLA to FDA MNK
11:07am, Monday, 06'th Apr 2020
Mallinckrodt subsidiary initiates rolling submission of StrataGraft BLA to FDA MNK
Mallinckrodt Plc:
Mallinckrodt plc (NYSE: MNK), a leading global specialty pharmaceutical company, today announced that Stratatech, a Mallinckrodt company, has initiated the rolling submission of a Biologics License Ap
Mallinckrodt (NYSE:MNK) Price Target Cut to $3.00 by Analysts at Barclays
09:26am, Monday, 06'th Apr 2020
Mallinckrodt (NYSE:MNK) had its target price reduced by Barclays from $5.00 to $3.00 in a research note released on Thursday, BenzingaRatingsTable reports. They currently have an equal weight rating o
